Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics (TADCAROC)
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 260
- 试验地点
- 1
- 主要终点
- The Anxiety Disorder Interview Schedule for Diagnostic and Statistical Manual (DSM-IV), child and parent versions (ADIS- C/P; Silverman & Albano, 1996).
研究概览
简要总结
The purpose of this study is to examine the content of the treatment being delivered for anxiety disorders for children and adolescents in the regular outpatient clinics in western Norway. The study will also collect data before and after treatment to evaluate the result of the treatment. Furthermore, as part of the study we aim to collect normative data on two questionnaires used to identify anxiety symptoms and the extent to which anxiety interfere with daily functioning. We also aim to develop a quality indicator for anxiety treatment that can be used to monitor treatment in the regular outpatient service, based on the results of the current study.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 7 Years 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of an anxiety disorder (including PTSD and OCD) based on the diagnostic interview ADIS (ADIS-C/P; Silverman & Albano, 1996).
- •The anxiety disorder is the patients primary diagnosis.
- •Informed concent is given.
排除标准
- •The patient is in need for other primary treatment intervention (e.g., psychosis, suicidality risk)
结局指标
主要结局
The Anxiety Disorder Interview Schedule for Diagnostic and Statistical Manual (DSM-IV), child and parent versions (ADIS- C/P; Silverman & Albano, 1996).
时间窗: The primary outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.
Diagnostic interview for anxiety disorders and other comorbid disorders. For the 10-year follow-up we anticipate to use another version of the diagnostic interview schedule based on revised diagnostic criteria for anxiety disorders.
次要结局
- Children's Anxiety Life Interference Scale (CALIS; Lyneham et al., 2013)(This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).)
- Spence Children's Anxiety Scale (SCAS; Spence, 1998)(This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).)
- Short Mood & Feeling Questionaire (SMFQ; Angold et al., 1995).(This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks))
- The Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1999).(This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).)
- The Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997)(This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks))
- Clinical Global Impressions (CGI; Guy, 1976).(The outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.)